Search research articles
Contact Us
Filters
Showing results (61-70 of 89) with videos related to
Page
of 9
Sort By:
The Journal of Experimental Medicine
|
September 19, 2025
Correction: Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation
Kaiting Yang, Yuzhu Hou, Yuan Zhang, et al.
The Journal of Experimental Medicine
|
January 26, 2021
Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation
Kaiting Yang, Yuzhu Hou, Yuan Zhang, et al.
JAMA Oncology
|
July 20, 2023
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial
Rohan R Katipally, Carlos A Martinez, Siân A Pugh, et al.
Oncotarget
|
April 2, 2016
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
Diana Rose E Ranoa, Akash D Parekh, Sean P Pitroda, et al.
Cancer
|
May 21, 2016
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)
Anthony C Wong, Sydeaka P Watson, Sean P Pitroda, et al.
Endocrine-Related Cancer
|
February 16, 2022
Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumors
Olga Lakiza, Julian Lutze, Alyx Vogle, et al.
Journal of Visualized Experiments : Jove
|
December 9, 2016
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Go Oshima, Melinda E Stack, Sean C Wightman, et al.
Clinical and Translational Radiation Oncology
|
November 12, 2024
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma
Daniel Huang, Connor Lynch, Lucas M Serra, et al.
The Journal of Experimental Medicine
|
November 6, 2025
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function
Dapeng Chen, Liangliang Wang, Chuangyu Wen, et al.
Clinical Lung Cancer
|
September 6, 2024
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer
Christine M Bestvina, Jared H L Hara, Theodore Karrison, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 89) with videos related to
Sort By:
Page
of 9
The Journal of Experimental Medicine
|
September 19, 2025
Correction: Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation
Kaiting Yang, Yuzhu Hou, Yuan Zhang, et al.
The Journal of Experimental Medicine
|
January 26, 2021
Suppression of local type I interferon by gut microbiota-derived butyrate impairs antitumor effects of ionizing radiation
Kaiting Yang, Yuzhu Hou, Yuan Zhang, et al.
JAMA Oncology
|
July 20, 2023
Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial
Rohan R Katipally, Carlos A Martinez, Siân A Pugh, et al.
Oncotarget
|
April 2, 2016
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs
Diana Rose E Ranoa, Akash D Parekh, Sean P Pitroda, et al.
Cancer
|
May 21, 2016
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)
Anthony C Wong, Sydeaka P Watson, Sean P Pitroda, et al.
Endocrine-Related Cancer
|
February 16, 2022
Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumors
Olga Lakiza, Julian Lutze, Alyx Vogle, et al.
Journal of Visualized Experiments : Jove
|
December 9, 2016
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Go Oshima, Melinda E Stack, Sean C Wightman, et al.
Clinical and Translational Radiation Oncology
|
November 12, 2024
Primary site stereotactic ablative body radiotherapy in localized, recurrent, and metastatic renal cell carcinoma
Daniel Huang, Connor Lynch, Lucas M Serra, et al.
The Journal of Experimental Medicine
|
November 6, 2025
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function
Dapeng Chen, Liangliang Wang, Chuangyu Wen, et al.
Clinical Lung Cancer
|
September 6, 2024
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer
Christine M Bestvina, Jared H L Hara, Theodore Karrison, et al.
Page
of 9